Australia vs Central African Republic: The number of people with susceptibility test result for rifampicin

Australia
597
in 2021
Central African Republic
660
in 2021
Australia rank
76th
Central African Republic rank
73rd

The number of people with susceptibility test result for rifampicin over time

  • Australia
  • Central African Republic
0200400600800201720192021

How they compare

Central African Republic currently reports 660 against 597 in Australia, a difference of 63.

That makes Central African Republic's figure about 1.1 times Australia's.

The two have swapped places 1 time across 5 shared years of data; in 2017 it was Australia ahead.

Australia ranks 76th and Central African Republic ranks 73rd of 155 countries.

Australia has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade Australia Central African Republic Difference Ahead
2010s 702.67 101.67 601 Australia
2020s 666 665.5 0.5 Australia

Averages of every year both report within each decade.

Frequently asked questions

Which has higher the number of people with susceptibility test result for rifampicin, Australia or Central African Republic?
Central African Republic, at 660 against 597 in Australia as of 2021.
What is the difference in the number of people with susceptibility test result for rifampicin between Australia and Central African Republic?
63, with Central African Republic ahead.
How many years of comparable data are there for Australia and Central African Republic?
5 years are reported by both, from 2017 to 2021.
How do Australia and Central African Republic rank globally for the number of people with susceptibility test result for rifampicin?
Australia ranks 76th and Central African Republic ranks 73rd of 155 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Australia vs Central African Republic: The number of people with susceptibility test result for rifampicin. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 17 September 2026, from https://health.statizoid.com/compare/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/australia/central-african-republic/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/australia/central-african-republic/">Australia vs Central African Republic: The number of people with susceptibility test result for rifampicin</a> — Statizoid

About this data

Indicator
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
157 places, 785 data points, 2017–2021
Last refreshed